the islands and no autochthonous cases of malaria have been reported from the Bahamas [12] . Carter [131 has written on the history of yellow fever. He studied in detail the passage of yellow fever through a community, attempting to define the incubation period of the disease. Josiah Clark Nott, a Connecticut native, settled in Alabama, had opportunity to study yellow fever at close hand in Alabama. In one epidemic affecting Mobile [14] , he lost four of his children, even though he had moved them to the country, outside of the stricken city. His observations on epidemic spread led him to postulate an insect vector for yellow fever [15] . His hypotheses are not precise, formulated as they were fifty years before the first demonstration of a mosquito vector of disease. Beauperthuy, a physician working in Angostura (later Ciudad Bolivar), Venezuela, advanced a similar hypothesis several years later [16] . Nott was a keen observer and set forth clearly his views that yellow fever was what we would call today a disease with a wide spectrum of clinical manifestations, ranging from mild illness in many cases, sometimes with no or very low fever, to cases with a fulminating onset, often terminating, in but four or five days, in death. Carlos Finlay, working in Havana, Cuba, advanced again the hypothesis of a mosquito vector of yellow fever [17] , and backed up this hypothesis with experimental work, attempting to show that Aedes aegypti, then known as Stegomyia fasciata, could be infected by and transmit yellow fever. The U.S. Army group in Havana, detailed to determine how yellow fever was spread, examined existing theories and was particularly impressed by Finlay's 1881 mosquito hypothesis. This, coupled with Carter's observations made in Mississippi in 1898, suggesting an incubation from first infecting case to later secondary cases of from two to three weeks, influenced Walter Reed and his associates to explore mosquito vectors. Their deductions were correct, and they made a convincing demonstration of yellow fever transmission to human volunteers by the bite of infected Aedes aegypti [18] . The control of the demonstrated vector brought yellow fever under control in the major port cities of the Old World and the New World. It was thought, in the early decades of the twentieth century, that the disease could be vanquished. However, some unexplained outbreaks of yellow fever continued to be seen, particularly in the hinterlands of South America. Soper and co-workers published a paper [19] which caused anguish. They described yellow fever in the State of Espirito Santo, Brazil, in the absence of Aedes aegypti. Mosquitoes of the genus Haemagogus, a genus quite closely related to Aedes, were shown to be the vectors for a jungle (or sylvan, or forest) cycle of yellow fever, in which forest primates served as the vertebrate host, in places where man was only an occasional invader and, in effect, an accidental host, not responsible for long-term maintenance of the disease. Bugher et al. [20] describe the observations of Boshell Manrique that mosquitoes of this genus appeared suddenly at ground level when trees were being felled. This observation led to numerous later studies on the species composition and vertical distribution of mosquito populations (and populations of other biting arthropods) and carried disease epidemiology into the forest canopy. Mosquitoes of several other genera in the New World were shown to be possible vectors. In the Old World, Aedes of several species were shown to maintain a cycle of jungle yellow fever, and mosquitoes of several other genera were shown to be secondarily involved. Virus was even isolated once from a Phlebotomus fly.
Thoughts of overall control were banished, but also, it was apparent that the protection of major population centers remained possible through urban A. aegypti control programs.
Another control methodology was introduced in the mid-thirties with the development of yellow fever vaccines. French workers developed a mouse brain vaccine from the French neurotropic strain of virus, given by scarification. Successive modifications were made, with the vaccine of Peltier and Durieux [21] being used for immunization of millions in the French West African colonies. The vaccine, often administered with smallpox vaccine, induced a high degree of immunity, but there were also vaccine reactions, some of them, particularly in small children, of encephalitic type. This vaccine has been almost entirely supplanted by the attenuated 17D vaccine, developed by Theiler and Smith [22] , and now in use worldwide; it is produced in embryonated chicken eggs. Reactions to the 17D vaccine are uncommon. Immunity induced is very long-lasting, quite possibly lifelong.
Each of these control options is flawed. The early techniques developed for control of the vector were refined to the point where Soper et al. [23] in a campaign backed by the Brazilian government and the Rockefeller Foundation, announced the eradication of Aedes aegypti from Brazil. The massive operation was successful, in the era before DDT was known. When the new insecticides, heralded by DDT, did arrive it appeared that Soper's painstaking strategy for mosquito control could be extended and simplified, and at least in the New World the possibility of hemispheric eradication was entertained. Aedes aegypti was eradicated from many Central and South American countries. Nature again showed her colors, and gloom succeeded happiness when it was shown, in the late 1950s, that the mosquitoes were developing a resistance to DDT and also to other insecticides. The mosquito reinvaded many areas where it had been eradicated, and, following its reappearance and multiplication, dengue epidemics (also Aedes aegypti transmitted) are being seen annually in the West Indies and northern South America. The risk of reappearance of urban yellow fever is obvious. This brings us to the second point, the vaccine, which can be afforded and which can protect any person or population immunized. An immunization program reaching all the population at risk is difficult to conduct. The risk perceived does not appear commensurate with the effect involved, and in very few places are continuing effective vaccination programs in operation today. The problem for the individual, be this individual an international traveler or a concerned individual living in a yellow fever endemic locale, is not a difficult one. But for the populations in the hinterlands of Africa or the Americas, it remains a large problem. The vaccine is not very heat stable, and requires a "cold chain" in order to guarantee conformity of the vaccine being administered with International Regulations. The development of the air jet vaccination apparatus accelerates a mass vaccination campaign greatly. In the event of an outbreak in a major city, today's approach is to start an immunization program immediately, and to do a thorough mosquito cleanup, treating and if possible destroying all Aedes breeding places. An immediate campaign of adulticiding, hoping to kill any infected mosquitoes, as well as reducing the numbers of mosquitoes, is mounted, with insecticide fogs laid down by aircraft, and by specially adapted ground-based spraying and fogging vehicles and portable sprayers. This approach is practical and assures prompt epidemic control. However, if diagnosis of the first case(s) is not made early, an urban epidemic could well be in the second or third wave of transmission before control gets started, and there might easily be several hundred individuals infected, with many deaths.
The unfolding of the jungle yellow fever story, and the implication of primates of both Old World and New World in a cycle of virus transmission high in the canopy of tropical rain forests seemed like too simplistic a story to satisfy the critical investigator. Bugher, in the chapter entitled "The Mammalian Host in Yellow Fever" [29] claimed to have transmitted yellow fever to a human volunteer (those were heroic days of epidemiology) by bite of Aedes aegypti reared from an egg of an Aedes which had been permitted to bite on a yellow fever patient. Unhappily, the data leave doubt as to the validity of the observation. A number of later studies failed to confirm the hypothesis of transovarial transmission of virus.
Rosen et al. [30] succeeded in demonstrating transovarial passage of the viruses of Japanese encephalitis and of dengue and this work was soon followed by demonstration of transovarial passage of the yellow fever virus in Aedes aegypti by Beaty, Tesh, and Aitken [31] . These breakthroughs were made possible through use of newly developed techniques of immunofluorescence and "tagged" antibody which permitted rapid examination of hundreds of thousands of individual mosquitoes.
The phenomenon demonstrated for yellow fever is a low-level phenomenon, successful transovarial passage being at about a 1 percent level. Studies are being undertaken involving several strains of A. aegypti, other vectors, and other strains of virus in order to know how far one dares to extrapolate from what has been observed. Concurrent with these laboratory studies there are field observations from Africa providing new insights and highlighting new avenues for exploration. Cornet et al. [5] report Institut Pasteur field studies in the vicinity of Kedougou in southeast Senegal. They have made numerous isolations of yellow fever from mosquitoes of the Aedes taylori-furcifer complex. Isolations have been made from female and male mosquitoes. There has been no overt evidence of yellow fever activity in the region, as evidenced by recognizable cases of illness in man or monkeys. This focus remained active for two years, after which the virus has disappeared. The mosquito complex is under intensive study and it appears that it will be possible to identify the two Aedes species in field-collected material, and to subject each species to detailed studies of susceptibility, life cycle, and behavior, including feeding preferences. Germain et al. [32] 
